1. Home
  2. BUUU vs CLNN Comparison

BUUU vs CLNN Comparison

Compare BUUU & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUUU

BUUU Group Limited Class A Ordinary Share

N/A

Current Price

$7.98

Market Cap

133.4M

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.77

Market Cap

120.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUUU
CLNN
Founded
2017
2012
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.4M
120.6M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
BUUU
CLNN
Price
$7.98
$5.77
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$32.67
AVG Volume (30 Days)
44.6K
305.1K
Earning Date
12-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$6,328,425.00
$214,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$87.58
P/E Ratio
$150.87
N/A
Revenue Growth
8.88
N/A
52 Week Low
$3.67
$2.28
52 Week High
$9.50
$13.50

Technical Indicators

Market Signals
Indicator
BUUU
CLNN
Relative Strength Index (RSI) N/A 32.08
Support Level N/A $8.90
Resistance Level N/A $9.92
Average True Range (ATR) 0.00 1.03
MACD 0.00 -0.40
Stochastic Oscillator 0.00 2.12

Price Performance

Historical Comparison
BUUU
CLNN

About BUUU BUUU Group Limited Class A Ordinary Share

BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: